Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia

Goldhaber-Fiebert JD 1 , Li H , Ratanawijitrasin S , Vidyasagar S , Wang XY , Aljunid S Show all authors , Shah N , Wang Z , Hirunrassamee S , Bairy KL , Wang J , Saperi S , Nur AM , Eggleston K

Affiliations 

  • 1 Centers for Health Policy and Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, CA 94305, USA
Diabet Med, 2010 Jan;27(1):101-8.
PMID: 20121896 DOI: 10.1111/j.1464-5491.2009.02874.x

Abstract

The prevalence of Type 2 diabetes mellitus (DM) has grown rapidly, but little is known about the drivers of inpatient spending in low- and middle-income countries. This study aims to compare the clinical presentation and expenditure on hospital admission for inpatients with a primary diagnosis of Type 2 DM in India, China, Thailand and Malaysia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications